ABVX
Price
$77.28
Change
+$2.85 (+3.83%)
Updated
Aug 22 closing price
Capitalization
5.49B
16 days until earnings call
VYNE
Price
$0.33
Change
+$0.01 (+3.12%)
Updated
Aug 22 closing price
Capitalization
6.6M
Interact to see
Advertisement

ABVX vs VYNE

Header iconABVX vs VYNE Comparison
Open Charts ABVX vs VYNEBanner chart's image
Abivax SA
Price$77.28
Change+$2.85 (+3.83%)
Volume$1.38M
Capitalization5.49B
VYNE Therapeutics
Price$0.33
Change+$0.01 (+3.12%)
Volume$1.48M
Capitalization6.6M
ABVX vs VYNE Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. VYNE commentary
Aug 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and VYNE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2025
Stock price -- (ABVX: $77.28 vs. VYNE: $0.33)
Brand notoriety: ABVX and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 77% vs. VYNE: 57%
Market capitalization -- ABVX: $5.49B vs. VYNE: $6.6M
ABVX [@Biotechnology] is valued at $5.49B. VYNE’s [@Biotechnology] market capitalization is $6.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileVYNE’s FA Score has 2 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • VYNE’s FA Score: 2 green, 3 red.
According to our system of comparison, VYNE is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while VYNE’s TA Score has 5 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 4 bearish.
  • VYNE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VYNE is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а +9.71% price change this week, while VYNE (@Biotechnology) price change was -4.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Reported Earning Dates

ABVX is expected to report earnings on Sep 08, 2025.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($5.49B) has a higher market cap than VYNE($6.6M). ABVX YTD gains are higher at: 955.738 vs. VYNE (-90.030). VYNE has higher annual earnings (EBITDA): -42.58M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. VYNE (39.6M). VYNE has less debt than ABVX: VYNE (25K) vs ABVX (92.6M). VYNE has higher revenues than ABVX: VYNE (476K) vs ABVX (0).
ABVXVYNEABVX / VYNE
Capitalization5.49B6.6M83,192%
EBITDA-170.04M-42.58M399%
Gain YTD955.738-90.030-1,062%
P/E RatioN/A0.71-
Revenue0476K-
Total Cash104M39.6M263%
Total Debt92.6M25K370,400%
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXVYNE
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWWNX91.051.18
+1.31%
American Funds New World 529-F-3
PAGLX45.85N/A
N/A
T. Rowe Price Global Growth Stock Adv
RTDTX16.56N/A
N/A
Russell Inv Multifactor US Equity M
DLCFX16.57N/A
N/A
Destinations Large Cap Equity I
RKCIX11.01N/A
N/A
Rockefeller Climate Solutions Instl

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with NEVPF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+3.83%
NEVPF - ABVX
65%
Loosely correlated
N/A
IMNN - ABVX
58%
Loosely correlated
-1.07%
CLSD - ABVX
51%
Loosely correlated
+1.04%
ANEB - ABVX
46%
Loosely correlated
+5.69%
MLTX - ABVX
39%
Loosely correlated
+3.18%
More

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with NEVPF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
+3.47%
NEVPF - VYNE
52%
Loosely correlated
N/A
SYRE - VYNE
36%
Loosely correlated
+3.58%
ABVX - VYNE
34%
Loosely correlated
+3.83%
EYPT - VYNE
32%
Poorly correlated
+1.98%
CRDF - VYNE
31%
Poorly correlated
+2.65%
More